- Country: Philippines
- Summary: Procurement of Drugs & Medicines Rfq No. 284
- PHT Ref No: 120774415
- Deadline: 18 Jun 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: PHP 248360.00
- Notice Type: Tender
- Document Ref. No.: RFQ#284
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Tender are invited for Procurement of Drugs & Medicines RFQ No. 284
Procurement Mode : Negotiated Procurement - Small Value Procurement (Sec. 53.9)
Classification : Goods
Category : Drugs and Medicines
Contract Duration : 15 Day/s
Budget for the Contract : PHP 248,360.00
Area of Delivery : Surigao Del Sur
Description : 1 PARACETAMOL 1G/100ML VIAL 600 VIAL 150.00 90,000.00
2 OCTREOTIDE 100MCG/ML, 1ML AMPULE 20 AMPULE 600.00 12,000.00
3 ONDANSETRON 2MG/ML, 4ML AMPULE 200 AMPULE 150.00 30,000.00
4 SUGAMMADEX 100MG/ML, 2ML VIAL 20 VIAL 5,818.00 116,360.00
Trade Agreement : Implementing Rules and Regulations - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINProcurement of Drugs & Medicines Rfq No. 284 - Philippines Tender
The ADELA SERRA TY MEMORIAL MEDICAL CENTER, a Government sector organization in Philippines, has announced a new tender for Procurement of Drugs & Medicines Rfq No. 284. This tender is published on PhilippinesTenders under PHT Ref No: 120774415 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-06-18.
The estimated tender value is PHP 248360.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
